Bioinspired by tunicates and mussels, a Korean research team has created a “bomb-like” anticancer therapeutic agent that only destroys cancer cells.
The nanobomb produces heat in precise sites where near-IR (NIR) laser is irradiated to create nitric oxide gas, which has an anticancer effect and concurrently discharges anticancer drugs to accomplish the trimodal treatment of photothermal-gas-chemo-therapy.
The POSTECH research team was headed by Professor Hyung Joon Cha and Dr. Yeonsu Jeong (Department of Chemical Engineering) in partnership with Professor Yun Kee Jo’s team at Kyungpook National University (Department of Biomedical Convergence Science and Technology, School of Convergence).
The researchers engineered a photoactivatable adhesive nanobomb with mussel adhesive proteins (MAPs) and the catechol-vanadium complex of tunicates that involves light-associated energy conversion through electron transfer. The term ‘photoactivatable’ denotes the characteristic where properties vary based on the external light.
Since cancer manifests via multiple biological pathways, a process that integrates several treatments rather than one single treatment is generally employed. But it is challenging to deliver several therapeutic agents at once to a particular cancer site because of the large amount of fluid found in the human body.
Among such approaches, light-triggered photothermal therapy (PTT) employs nanoparticles of metals, synthetic polymers or carbon. However, their weak biodegradability, which can cause a hazard of systemic toxicity, and low photothermal conversion efficiency — the efficiency at which the captured light is turned to heat — render effective cancer treatment tough.
To this, the researchers developed nanoparticles by incorporating the catechol-vanadium complexes — which help electrons and light travel in tunicates — to the MAP. When these nanoparticles are exposed to the light from NIR lasers, the temperature can be increased to 50 degrees within 5 minutes, displaying exceptional photothermal conversion efficiency of around 50%.
These nanoparticles can be retained on cancer cells for an extended period owing to the robust adhesiveness of MAP. Furthermore, the excellent biocompatibility and biodegradability of proteinic nanoparticles resolve the safety matter of traditional light-responsive nanotherapeutics.
When the nanoparticles comprising a thermo-sensitive nitric oxide (NO) donor and an anticancer drug were irradiated using the near-IR (NIR) laser, NO gas and drugs were effectively discharged due to the photothermal effect, verifying their likelihood for use in a nanobomb.
It is generally tough to retain the anticancer effects of NO gas as it rapidly biometabolizes. However, the nanobomb can regulate the release of gas with light, which significantly raises the delivery efficiency of NO.
In preclinical testing in animal models, the tumor grew back 15 days after being treated with only a single photothemal treatment, whereas the therapeutic effectiveness was extended with trimodal treatments using nanobombs as no tumors were seen for around 1 month.
With a single nanoparticle, various site-specific therapeutic agents can be locally administered and multimodal treatments can be easily controlled with a single stimulus, which will be effective in treating cancer patients in the future.
Professor Hyung Joon Cha, Department of Chemical Engineering, Pohang University of Science and Technology
“This nanobomb can be applied not only to photothermal-gas-chemo-therapy, but also to the delivery of therapeutics including genes and antibodies or contrast agents, and therefore can be widely used according to the specific needs of the patient or the condition,” Professor Hyung Joon Cha added.
This research was chosen as the front cover paper of the December issue of Advanced Healthcare Materials, a well-known journal in the domain of materials science.
The research was performed with the support from the National Research Foundation grant funded by the Ministry of Science and ICT of Korea, the National Research Foundation grant funded by the Ministry of Education of Korea, and the Marine BioMaterials Research Center grant funded by the Ministry of Oceans and Fisheries of Korea.
The mussel adhesive protein technology has gone through a technology transfer to Nature Glutech Co., Ltd., and clinical trials will take place after procuring investigational new drug (IND) approvals.
News
Lower doses of immunotherapy for skin cancer give better results, study suggests
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National [...]
Researchers highlight five pathways through which microplastics can harm the brain
Microplastics could be fueling neurodegenerative diseases like Alzheimer's and Parkinson's, with a new study highlighting five ways microplastics can trigger inflammation and damage in the brain. More than 57 million people live with dementia, [...]
Tiny Metal Nanodots Obliterate Cancer Cells While Largely Sparing Healthy Tissue
Scientists have developed tiny metal-oxide particles that push cancer cells past their stress limits while sparing healthy tissue. An international team led by RMIT University has developed tiny particles called nanodots, crafted from a metallic compound, [...]
Gold Nanoclusters Could Supercharge Quantum Computers
Researchers found that gold “super atoms” can behave like the atoms in top-tier quantum systems—only far easier to scale. These tiny clusters can be customized at the molecular level, offering a powerful, tunable foundation [...]
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
WASHINGTON -- A single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer, researchers reported Wednesday. HPV, or human papillomavirus, is very common and spread [...]
New technique overcomes technological barrier in 3D brain imaging
Scientists at the Swiss Light Source SLS have succeeded in mapping a piece of brain tissue in 3D at unprecedented resolution using X-rays, non-destructively. The breakthrough overcomes a long-standing technological barrier that had limited [...]
Scientists Uncover Hidden Blood Pattern in Long COVID
Researchers found persistent microclot and NET structures in Long COVID blood that may explain long-lasting symptoms. Researchers examining Long COVID have identified a structural connection between circulating microclots and neutrophil extracellular traps (NETs). The [...]
This Cellular Trick Helps Cancer Spread, but Could Also Stop It
Groups of normal cbiells can sense far into their surroundings, helping explain cancer cell migration. Understanding this ability could lead to new ways to limit tumor spread. The tale of the princess and the [...]
New mRNA therapy targets drug-resistant pneumonia
Bacteria that multiply on surfaces are a major headache in health care when they gain a foothold on, for example, implants or in catheters. Researchers at Chalmers University of Technology in Sweden have found [...]
Current Heart Health Guidelines Are Failing To Catch a Deadly Genetic Killer
New research reveals that standard screening misses most people with a common inherited cholesterol disorder. A Mayo Clinic study reports that current genetic screening guidelines overlook most people who have familial hypercholesterolemia, an inherited disorder that [...]
Scientists Identify the Evolutionary “Purpose” of Consciousness
Summary: Researchers at Ruhr University Bochum explore why consciousness evolved and why different species developed it in distinct ways. By comparing humans with birds, they show that complex awareness may arise through different neural architectures yet [...]
Novel mRNA therapy curbs antibiotic-resistant infections in preclinical lung models
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria. The findings, published in Nature Biotechnology, show that in [...]
New skin-permeable polymer delivers insulin without needles
A breakthrough zwitterionic polymer slips through the skin’s toughest barriers, carrying insulin deep into tissue and normalizing blood sugar, offering patients a painless alternative to daily injections. A recent study published in the journal Nature examines [...]
Multifunctional Nanogels: A Breakthrough in Antibacterial Strategies
Antibiotic resistance is a growing concern - from human health to crop survival. A new study successfully uses nanogels to target and almost entirely inhibit the bacteria P. Aeruginosa. Recently published in Angewandte Chemie, the study [...]
Nanoflowers rejuvenate old and damaged human cells by replacing their mitochondria
Biomedical researchers at Texas A&M University may have discovered a way to stop or even reverse the decline of cellular energy production—a finding that could have revolutionary effects across medicine. Dr. Akhilesh K. Gaharwar [...]
The Stunning New Push to Protect the Invisible 99% of Life
Scientists worldwide have joined forces to build the first-ever roadmap for conserving Earth’s vast invisible majority—microbes. Their new IUCN Specialist Group reframes conservation by elevating microbial life to the same urgency as plants and [...]
